共 50 条
- [41] Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment [J]. FRONTIERS IN IMMUNOLOGY, 2021, 12
- [43] Covid-19 and lack of linked datasets for care homes [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
- [46] COVID-19: Cost-Benefit Analysis and Politics [J]. OSGOODE HALL LAW JOURNAL, 2020, 57 (03): : 537 - 565
- [47] A cost–benefit analysis of COVID-19 lockdowns in Australia [J]. Monash Bioethics Review, 2022, 40 : 62 - 93